A Nuclear Combination in Heterogeneous Metastatic Neuroendocrine Tumors

#1820

Introduction: Therapy with 177Lu-DOTATATE provides an objective response in neuroendocrine tumors (NET).

Aim(s): A clinical case of a metastatic NET with different grades of differentiation treated with PRRT and chemotherapy is presented.

Materials and methods: Clinical data were reviewed.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Sousa V, Timóteo T, Loewenthal C, Vieira R,

Keywords: PRRT,68Ga-DOTANOC,